Your browser doesn't support javascript.
loading
A design approach to the structural analysis of interleukin-2.
Ciardelli, T L; Landgraf, B; Gadski, R; Strnad, J; Cohen, F E; Smith, K A.
Afiliação
  • Ciardelli TL; Department of Pharmacology, Dartmouth Medical School, Hanover, NH 03756.
J Mol Recognit ; 1(1): 42-7, 1988 Feb.
Article em En | MEDLINE | ID: mdl-3273651
ABSTRACT
A semi-synthetic protein design approach has been employed for the structural investigation of a putative helical region at the C-terminus of Interleukin-2. With crystallographic or NMR derived conformational data as yet unavailable, we have relied only on primary sequence information and computer-assisted modelling to direct the analysis. By employing both chemical peptide synthesis and recombinant DNA methods, the C-terminus of IL-2 was modified according to a strategy designed to stabilize helical secondary structure. A semi-synthetic protein incorporating 12 simultaneous amino acid replacements was constructed, which possessed potentiated biological activity and displayed a far UV circular dichroism spectrum comparable to a hybrid protein with the authentic sequence. By comparison, another hybrid protein containing a C-terminal region designed to contain helix breaking residues was totally devoid of bioactivity. These findings provide evidence that the modelling method correctly identified a helix necessary for the formation of a bioactive tertiary fold. Moreover, by employing semi-synthesis it was possible to circumvent the difficulties associated with the preparation, purification and analysis of multiple recombinant proteins, and also to avoid the unreliability of total chemical synthesis for proteins greater than 100 residues.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Mol Recognit Ano de publicação: 1988 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Mol Recognit Ano de publicação: 1988 Tipo de documento: Article